Novo Nordisk

Apr 26, 2016 at 18:54 | Source: PTI
Haemophilia is a chronic, inherited bleeding disorder that primarily affects males. People with haemophilia A are either missing or have a malfunctioning factor VIII protein, which is essential for proper blood clotting.
Jul 17, 2015 at 09:49 | Source:
The pharma major has received an approval from the USFDA for PrandiMet (also known as Prandin) generic that is used for treatment of type 2 diabetes.
Oct 09, 2013 at 13:00 | Source: Reuters
The concept of oral insulin as a way to relieve people with type 1 diabetes of several daily injections has been around since the 1930s.
Sep 03, 2013 at 21:14 | Source: CNBC-TV18
Danish drug maker Novo Nordisk is all set to launch its ultra long-lasting insulin injection, brand named Tresiba, in India by the end of this year.
Feb 14, 2013 at 10:18 | Source:
Biocon shares rose 2 percent in morning trade on Thursday after the biotechnology company said it has enhanced its partnership with pharma major Mylan through a strategic collaboration for insulin products.
Apr 18, 2012 at 14:20 | Source:
Shares of pharma major Sun Pharmaceutical Industries rose over 2.5% on Wednesday, after US Supreme Court gave a verdict in favour of its arm Caraco Pharmaceutical Laboratories in the ongoing battle with Novo Nordisk for a generic version of diabetic drug Prandin.
Apr 17, 2012 at 20:36 | Source: Reuters
The US Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to market.
Apr 16, 2012 at 18:54 | Source: CNBC-TV18
Novo Nordisk, in association with CNBC-TV18, presents "Improving Control of Diabetes Pandemic in India". In this discussion, experts address the challenges and management of diabetes in India.
Mar 20, 2012 at 21:43 | Source: CNBC-TV18
Multi-national drug companies are queuing up to enter India and tap its growing anti-diabetes drug market. But Novo Nordisk, which has been in the Indian insulin market for 75 years, is not worried, reports CNBC-TV18's Archana Shukla.
Mar 13, 2012 at 10:30 | Source:
Pfizer - Biocon alliance has called off due to individual priorities and in Shares of Biocon fell more than 8% on Tuesday morning after US pharma major Pfizer scrapped a deal to sell insulin products made by the Bangalore-based biotechnology company.
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.